Brittany Johnson
Family · Murfreesboro, TNNPI 1336853480
Payments from drug & device makers
Across 105 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$554
- Novo Nordisk$406
- GSK$261
- Exact Sciences$158
- Boehringer Ingelheim$139
- Amgen$117
- plus $702 from 18 others
What the payments were for
- Food & beverage$2,336100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $554 |
| Novo Nordisk | 21 | $406 |
| GSK | 13 | $261 |
| Exact Sciences | 4 | $158 |
| Boehringer Ingelheim | 8 | $139 |
| Amgen | 1 | $117 |
| Lilly USA, LLC | 4 | $101 |
| Corcept Therapeutics | 4 | $78 |
| Novartis | 5 | $74 |
| Bayer | 4 | $72 |
| Corium, LLC | 4 | $71 |
| BD | 1 | $44 |
| Halozyme Inc | 2 | $39 |
| Johnson & Johnson | 2 | $32 |
| AstraZeneca | 2 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Pfizer | 1 | $17 |
| Indivior Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cologuard Collection Kit$124
- Repatha$117
- QULIPTA$110
- UBRELVY$110
How this compares
$2,336 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $13,771 |
| Atorvastatin Calcium | 39 | $600 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $572 |
| Gabapentin | 17 | $369 |
| Pantoprazole Sodium | 13 | $348 |
| Metoprolol Succinate | 15 | $306 |
| Levothyroxine Sodium | 22 | $265 |
| Omeprazole | 18 | $201 |
| Fluticasone Propionate | 16 | $156 |
| Sertraline Hcl | 16 | $135 |
| Lisinopril | 29 | $124 |
| Metformin Hcl | 12 | $117 |
| Meloxicam | 20 | $46 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $261 | $13,77116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.
Other family in Murfreesboro
- Cynthia MillerMurfreesboro$384K
- Melanie McGheeMurfreesboro$48K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.